ROCKVILLE, Md.--(BUSINESS WIRE)--Neogenix Oncology announced today organizational changes and the appointment of key advisors with industry expertise to support commercialization, legal and SEC public reporting and compliance requirements. The expanded team includes The Bethesda Financial Group for finance management and SEC reporting; Greenberg Traurig as legal counsel; Hunton &Williams as IP counsel; and Maxim Group LLC as advisor and placement agent. They will join Neogenix Oncology’s CEO, Dr. Philip M. Arlen, and COO, Albine Martin, PhD, in building the team as the company continues to achieve projected milestones.
